New rebate model: Trump's pilot ties 340B discounts to verified claims, aiming to ensure savings benefit eligible patients and curb abuse. Oversight gaps exposed: Lack of clear patient eligibility ...

The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

It's time for lawmakers to finally fix the 340B drug prescription program so it truly benefits our state's most vulnerable ...

On May 28, representatives from three states introduced a federal bill to amend the 340B program by recognizing contract pharmacies, restricting pharmacy benefit managers and tightening eligibility ...

The House Energy and Commerce Committee has advanced legislation that would have major impacts on payments in the 340B drug discount program, and providers are not pleased with the potential changes.

Despite dramatic expansion over the past 34 years, many rural and underserved hospitals continue to face significant ...

Two recent federal court cases signal new significant developments with respect to the 340B Drug Pricing Program. Specifically: (1) new federal district court litigation challenging a recent HRSA ...

The 340B drug plan language that was recently added into Senate Bill 494 risks increasing costs for the very patients it ...

Congress created the 340B drug discount program in 1992 with a simple premise: allow hospitals and federal grantees serving a ...

A periodic feature by Cornerstone Research, in which our affiliated experts, senior advisors, and professionals, talk about their research and findings. We interview Professor Sayeh Nikpay of the ...

One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and treatment is obtaining effective and safe drugs. Cancer treatment is often a long, taxing ...